COPENHAGEN, Denmark, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (NASDAQ:ASND) today announced that Jan Mikkelsen, President & Chief Executive Officer, Scott Smith, Executive Vice President & Chief Financial Officer, and Kennett Sprogøe, Ph.D., Executive Vice President, Head of Research & Product Development, will participate in the 42nd Annual J.P. Morgan Healthcare Conference.
Details:
Event | 42nd Annual J.P. Morgan Healthcare Conference |
Location | San Francisco, CA |
Date | Monday, January 8, 2024 |
Time | 12:00-12:40 p.m. Eastern Time / 9:00-9:40 a.m. Pacific Time |
A live webcast of the event will be available via the Investors & News section of the Ascendis Pharma website at investors.ascendispharma.com. A webcast replay will also be available on this website shortly after conclusion of the event for 30 days.
About Ascendis Pharma A/S